Pharmaceutical Industry Information Portal

HomePharmaceutical Investing News

Pharmaceutical Investing News

Cogent Biosciences begins $125 million public offering

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten public...

Bluejay Diagnostics shares down 31% after rising Thursday

Bluejay Diagnostics Inc. shares reversed course from Thursday's gains, dropping 31% to $1.12 one day after saying the Food and Drug Administration has agreed...

Moderna fell, Novavax rose – positive vaccine news caused mixed reactions

Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies regarding their COVID-19 vaccines. Moderna stock...

3D deep-learning research company Charm Therapeutics launches with $50m series A

CHARM Therapeutics (“CHARM”, “The Company”), announces today a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with General Catalyst, Khosla Ventures, Braavos...

Code Biotherapeutics raises $75 Million to advance programs to treat and cure rare and prevalent genetic diseases

Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and oversubscribed Series A financing...

AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from...
spot_img

Expert Articles

spot_img